Tested Applications
| Positive WB detected in | Human brain, human brain tissue |
| Positive IHC detected in | human testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
66072-1-Ig targets CPT1C in WB, IHC, IF, IP, ELISA applications and shows reactivity with human, pig samples.
| Tested Reactivity | human, pig |
| Cited Reactivity | human, mouse, rat, pig |
| Host / Isotype | Mouse / IgG2b |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag17963 Product name: Recombinant human CPT1C protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 442-793 aa of BC029104 Sequence: SFTLIVFSNGKLGLSVEHSWADCPISGHMWEFTLATECFQLGYSTDGHCKGHPDPTLPQPQRLQWDLPDQIHSSISLALRGAKILSENVDCHVVPFSLFGKSFIRRCHLSSDSFIQIALQLAHFRDRGQFCLTYESAMTRLFLEGRTETVRSCTREACNFVRAMEDKEKTDPQCLALFRVAVDKHQALLKAAMSGQGVDRHLFALYIVSRFLHLQSPFLTQVHSEQWQLSTSQIPVQQMHLFDVHNYPDYVSSGGGFGPADDHGYGVSYIFMGDGMITFHISSKKSSTKTDSHRLGQHIEDALLDVASLFQAGQHFKRRFRGSGKENSRHRCGFLSRQTGASKASMTSTDF Predict reactive species |
| Full Name | carnitine palmitoyltransferase 1C |
| Calculated Molecular Weight | 792 aa, 90 kDa |
| Observed Molecular Weight | 82 kDa |
| GenBank Accession Number | BC029104 |
| Gene Symbol | CPT1C |
| Gene ID (NCBI) | 126129 |
| RRID | AB_11042325 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein A purification |
| UNIPROT ID | Q8TCG5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
CPT1C, also named as CATL1, CPTI-B and B-CPTI, belongs to the carnitine/choline acetyltransferase family. Carnitine palmitoyltransferase (CPT) deficiencies are common disorders of mitochondrial fatty acid oxidation. The CPT system is made up of two separate proteins located in the outer (CPT1) and inner (CPT2) mitochondrial membranes. CPT1C is an active forms of related brain-type carnitine palmitoyltransferase I. CPT1C may be a regulated target of malonyl-CoA that relays the "malonyl-CoA signal" in hypothalamic neurons that express the orexigenic and anorexigenic neuropeptides that regulate food intake and peripheral energy expenditure. (PMID: 17018521 ) This antibody can bind the close sequences genes.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for CPT1C antibody 66072-1-Ig | Download protocol |
| WB protocol for CPT1C antibody 66072-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CPT1C antibody (Cat# 66072-1-Ig) has 10 total citations. These appear in journals including Mol Cancer, Hepatology, Cell Commun Signal, Cancer Metab, Int J Mol Sci, Sci Rep, Acta Biochim Biophys Sin, Epigenetics, J Biochem Mol Toxicol, and J Gastrointest Oncol. Research fields span multiple cancer types (lung, liver, breast, colorectal, gastric), fatty acid oxidation and lipid metabolism, adipogenesis, and cardiovascular disease. Applications include WB, IHC, IF, and IP.
| Species | Application | Title |
|---|---|---|
Mol Cancer Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma
| ||
Hepatology Discovery of a CPS1-deficient HCC subtype with therapeutic potential via integrative genomic and experimental analysis.
| ||
Cell Commun Signal APC/C-regulated CPT1C promotes tumor progression by upregulating the energy supply and accelerating the G1/S transition | ||
Cancer Metab MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation. | ||
Int J Mol Sci Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer
| ||
Sci Rep Combining machine learning and multi-omics analysis to explore the role of CPT1C in colorectal tumor cancer transformation. |





